Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure

Abstract

Although selective serotonin reuptake inhibitors (SSRIs) are routinely prescribed for acute stress disorder and early PTSD and recommended in the VA-DoD best practice guidelines, the efficacy of SSRIs as an early intervention for PTSD in service members returning from war-zone duty has still not been determined. Consequently, this study was designed to conduct a controlled trial of fluoxetine as an early intervention for recently redeployed soldiers, as well as to develop methodologies for understanding the multiple factors that may predict outcome. The study was conducted at two sites: Carl R. Darnall Army Medical Center and Central Texas Veterans Health Care System. Despite recruitment efforts, only 42 participants were enrolled. Of these, 18 were randomized. The limited enrollment obscures interpretation of the results. No unexpected side effects were observed. Our data does not support or refute the use of SSRIs for treatment of PTSD.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2013
Accession Number
ADA583752

Entities

People

  • Paul B. Hicks

Organizations

  • Tempva Research Group Inc.

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Anticonvulsants
  • Antidepressants
  • Anxiety Disorders
  • Brain
  • Brain Injuries
  • Chemistry
  • Drug Abuse
  • Drug Addiction
  • Enzyme Inhibitors
  • Health Services
  • Medical Personnel
  • Pharmacies
  • Tranquilizing Agents

Fields of Study

  • Medicine
  • Psychology

Readers

  • Clinical Trial Research.
  • Medical or Health Care Field.
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.